Search

everythinglearnresearchcommunity

for

Search:↓

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Higher minoxidil dose helps hair growth in non-responders without side effects.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

Sweat glands and hair follicles are determined by opposing signals, with BMPs promoting sweat glands and blocking BMPs leading to hair follicles.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Vitamin A affects hair loss and immune response in alopecia areata.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

The skin and thymus develop similarly to protect and support immunity.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Different stem cells have benefits and challenges for tissue repair, and more research is needed to find the best types for each use.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Researchers isolated a new type of stem cell from mouse skin that can renew itself and turn into multiple cell types.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

Dental pulp stem cells might not reliably become neurons.

ATP-dependent chromatin remodeling is crucial for skin development and stem cell function.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.